Research/Compounds/Longevity & Senolytics

Longevity & Senolytics

Research profiles for evidence-backed longevity compounds including mTOR inhibitors, metabolic interventions, senolytics, and NAD+ precursors.

Rapamycin
mTOR inhibitor — most evidence-backed longevity drug
FDA Approved (off-label)
Metformin
AMPK activator — anti-aging and metabolic
FDA Approved (off-label)
NAD+ Injectable
Direct NAD+ repletion — fastest route
Research
NMN
NAD+ precursor — oral or injectable
Research
Fisetin
Senolytic flavonoid — clears senescent cells
Research
Spermidine
Autophagy inducer — longevity and cardiac data
Research
C60
Carbon 60 — antioxidant, controversial longevity data
Research
Back to full compound library